Literature DB >> 26252943

Airway responsiveness to mannitol in asthma is associated with chymase-positive mast cells and eosinophilic airway inflammation.

A Sverrild1, A Bergqvist2, K J Baines3, C Porsbjerg1, C K Andersson2, S F Thomsen4, H J Hoffmann5, P Gibson3, J S Erjefält2, V Backer1.   

Abstract

BACKGROUND: Airway hyperresponsiveness (AHR) to inhaled mannitol is associated with indirect markers of mast cell activation and eosinophilic airway inflammation. It is unknown how AHR to mannitol relates to mast cell phenotype, mast cell function and measures of eosinophilic inflammation in airway tissue. We compared the number and phenotype of mast cells, mRNA expression of mast cell-associated genes and number of eosinophils in airway tissue of subjects with asthma and healthy controls in relation to AHR to mannitol.
METHODS: Airway hyperresponsiveness to inhaled mannitol was measured in 23 non-smoking, corticosteroid-free asthmatic individuals and 10 healthy controls. Mast cells and eosinophils were identified in mucosal biopsies from all participants. Mast cells were divided into phenotypes based on the presence of chymase. mRNA expression of mast cell-associated genes was measured by real-time PCR.
RESULTS: The proportion of submucosal MCTC was higher in asthmatic individuals with AHR to mannitol compared with asthmatic individuals without AHR (median: 40.3% vs. 18.7%, P = 0.03). Increased submucosal MCTC numbers were associated with increased levels of mRNA for thymic stromal lymphopoietin (TSLP) and CPA3 in asthmatics. Reactivity to mannitol correlated significantly with eosinophils in submucosa (r(s): 0.56, P = 0.01).
CONCLUSION: Airway hyperresponsiveness to inhaled mannitol is associated with an altered submucosal mast cell profile in asthmatic individuals. This mast cell profile is associated with increased levels of TSLP and CPA3. The degree of AHR to mannitol is correlated with the degree of eosinophilic inflammation in the airway submucosa.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  CPA3; TSLP; airway hyperresponsiveness; asthma; mannitol; mast cells

Mesh:

Substances:

Year:  2016        PMID: 26252943     DOI: 10.1111/cea.12609

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  11 in total

1.  Daily Inhaled Corticosteroids Treatment Abolishes Airway Hyperresponsiveness to Mannitol in Defence and Police Recruits.

Authors:  Clair D Lake; Keith K H Wong; Clare P Perry; Heikki O Koskela; John D Brannan
Journal:  Front Allergy       Date:  2022-05-31

2.  Non-specific airway hyperreactivity in asthma: a clinical correlate to … what exactly?

Authors:  L Borish
Journal:  Clin Exp Allergy       Date:  2016-02       Impact factor: 5.018

3.  Induction of mast cell accumulation by chymase via an enzymatic activity- and intercellular adhesion molecule-1-dependent mechanism.

Authors:  Huiyun Zhang; Junling Wang; Ling Wang; Mengmeng Zhan; Shigang Li; Zeman Fang; Ciyan Xu; Yanshan Zheng; Shaoheng He
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

4.  Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3.

Authors:  Premkumar Siddhuraj; Carl-Magnus Clausson; Caroline Sanden; Manar Alyamani; Mohammad Kadivar; Jan Marsal; Joanna Wallengren; Leif Bjermer; Jonas S Erjefält
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

Review 5.  Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases.

Authors:  Monica Thapaliya; Chalatip Chompunud Na Ayudhya; Aetas Amponnawarat; Saptarshi Roy; Hydar Ali
Journal:  Curr Allergy Asthma Rep       Date:  2021-01-04       Impact factor: 4.919

Review 6.  Comparison of methacholine and mannitol challenges: importance of method of methacholine inhalation.

Authors:  Donald W Cockcroft; Beth E Davis; Christianne M Blais
Journal:  Allergy Asthma Clin Immunol       Date:  2020-02-11       Impact factor: 3.406

Review 7.  The use of the mannitol test as an outcome measure in asthma intervention studies: a review and practical recommendations.

Authors:  Asger Sverrild; Joanna Leadbetter; Celeste Porsbjerg
Journal:  Respir Res       Date:  2021-11-07

Review 8.  Carboxypeptidase A3-A Key Component of the Protease Phenotype of Mast Cells.

Authors:  Dmitri Atiakshin; Andrey Kostin; Ivan Trotsenko; Vera Samoilova; Igor Buchwalow; Markus Tiemann
Journal:  Cells       Date:  2022-02-06       Impact factor: 6.600

9.  F eNO-based asthma management results in faster improvement of airway hyperresponsiveness.

Authors:  Katrine Feldballe Bernholm; Anne-Sophie Homøe; Howraman Meteran; Camilla Bjørn Jensen; Celeste Porsbjerg; Vibeke Backer
Journal:  ERJ Open Res       Date:  2018-10-03

10.  Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD.

Authors:  Vibeke Backer; Ditte K Klein; Uffe Bodtger; Kerstin Romberg; Celeste Porsbjerg; Jonas S Erjefält; Karsten Kristiansen; Ruiqi Xu; Alexander Silberbrandt; Laurits Frøssing; Morten Hvidtfeldt; Nicolai Obling; Linnea Jarenbäck; Abir Nasr; Ellen Tufvesson; Michiko Mori; Matilde Winther-Jensen; Lisa Karlsson; Ulf Nihlén; Thomas Veje Flintegaard; Leif Bjermer
Journal:  Eur Clin Respir J       Date:  2020-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.